Back

Disease-associated characteristics of cardiac endothelial cells and fibroblasts from a cardiomyocyte specific transgenic murine heart failure model

31 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Metabolic, immune, and cellular drivers of HFpEF pathogenesis and progression Heart Failure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mrs Caterina Redwanz

University Medicine Greifswald, Greifswald (Germany)

7 More presentations in this session

Presentation thumbnail
Functional phenotyping combined with single-cell sequencing unmasks potential genes for hypercontractility in murine HFpEF
Mr T. Jeising (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Nuclear receptor co-repressor 1 promotes macrophage inflammation in heart failure with preserved ejection fraction: a translational study
Doctor E. Gorica (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Cell-type specific secretome profiling reveals targets of liver-heart interorgan crosstalk in HFpEF and semaglutide treatment
Doctor J. Schuette (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Establishment of a female HFpEF model using Dahl salt-sensitive rats and investigation of sympathetic activation-induced acute exacerbation of HFpEF
Doctor H. Nakashima (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Connecting cardiac energetics to transcription factor control of heart failure and regeneration
Miss C. Zhu (Frankfurt Am Main, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Metabolic, immune, and cellular drivers of HFpEF pathogenesis and progression

The Event

Event poster

ESC Congress 2025

31 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Basic science
thumbnail
Congress Presentation
Geminin in proliferative endothelial cells regulates inflammation during heart failure development
thumbnail
Congress Presentation
Mural cell dysfunction contributes to diastolic heart failure by promoting endothelial dysfunction and vessel remodeling

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources